Medical News Today: This drug failed to treat cancer, but it could improve dementia

Dementia — an umbrella term for various neurodegenerative conditions involving memory loss and other forms of cognitive impairment — is hard to treat because its causes remain unknown. Researchers, however, are making painstaking progress. A new approach to dementia research may bring us closer to a treatment, but unexpected challenges could halt this progress. Dr.…

Details

Research into tropical eye worm yields new tests to assess safety of anti-filarial drugs

Researchers at the LSTM’s Centre for Drugs and Diagnostics, and University of Buea, Cameroon have developed new models of the tropical eye worm, Loa loa for the development of new drugs against filariasis. The research, led by Dr Joseph Turner at LSTM’s Department of Tropical Disease Biology, in collaboration with Professor Samuel Wanji’s team at…

Details

A new accurate computational method designed to enhance drug target stability

IMAGE: Structures of GPCRs solved with stabilizing mutations predicted by CompoMug. (a) serotonin 5-HT2c receptor (PDB:), (b) frizzled FZD4 receptor, © prostaglandin EP3 receptor and (d) cannabinoid CB2 receptor. Stabilizing amino… view more  Scientists from the Moscow Institute of Physics and Technology (MIPT), the Skolkovo Institute of Science and Technology (Skoltech), and the University of Southern…

Details

MSU lands $1.8 million NIH grant to improve brain implants

IMAGE: Michigan State University has landed a $1.8 million National Institutes for Health R01 grant to improve brain implants – “electroceuticals ” used to treat Alzheimer’s, Parkinson’s, depression and traumatic injuries…. view more  Credit: Courtesy of MSU EAST LANSING, Mich. – Michigan State University has landed a $1.8 million National Institutes for Health R01 grant to…

Details